Management of patients with diabetic hyperlipidemia

American Journal of Cardiology

Volumn 91, Issue 7 SUPPL. 1, 2003, Pages 24-28

  Knopp, Robert H ^a   Retzlaff, Barbara ^b   Aikawa, Keiko ^b   Kahn, Steven E ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; DILTIAZEM; ENALAPRIL; ESTRADIOL; ESTROGEN; FENOFIBRATE; FUROSEMIDE; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; NICOTINIC ACID; PIOGLITAZONE; TRIACYLGLYCEROL;

ADULT; CARDIOVASCULAR RISK; CASE REPORT; CLINICAL FEATURE; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DISEASE COURSE; FEMALE; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

EID: 0037417224     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)03385-4     Document Type: Conference Paper

References (32)

1. Mokdad A.H., Bowman B.A., Ford E.S., Vinicor F., Marks J.S., Koplan J.P. The continuing epidemics of obesity and diabetes in the United States. JAMA. 286:2001;1195-1200.
2. American Diabetes Association. Basic Diabetes Information. Available at: http://www.diabetes.org/main/application/commercewf?origin= *.jsp&event=link(B). Accessed May 6, 2002.
3. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes in the Unites States, rev. ed. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 1998.
4. Hulthe J., Bokemark L., Wikstrand J., Fagerberg B. The metabolic syndrome, LDL particle size, and atherosclerosis the Atherosclerosis and Insulin Resistance (AIR) study . Arterioscler Thromb Vasc Biol. 20:2000;2140-2147.
5. Laakso M., Lehto S., Penttila I., Pyorala K. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation. 88:1993;1421-1430.
6. Folsom A.R., Szklo M., Stevens J., Liao F., Smith R., Eckfeldt J.H. A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes the Atherosclerosis Risk in Communities (ARIC) Study . Diabetes Care. 20:1997;935-942.
7. Albrink M., Miegs W., Man J. Serum lipids, hypertension and coronary artery disease. Am J Med. 31:1961;4-23.
8. Albrink M.J., Lavietes P.H., Mann E.B. Vascular disease and serum lipids in diabetes mellitus observation of 30 years (1931-1961) . Ann Intern Med. 58:1963;305.
9. Santen R.J., Willis P.W. III, Fajans S.S. Atherosclerosis in diabetes mellitus correlations with serum lipid levels, adiposity, and serum insulin level . Arch Intern Med. 130:1972;833-843.
10. Kannel W.B., Castelli W.P., Gordon T., McNamara P.M. Serum cholesterol, lipoproteins, and the risk of coronary heart disease the Framingham Study . Ann Intern Med. 74:1971;1-12.
11. Fontbonne A., Eschwege E., Cambien F., Richard J.L., Ducimetiere P., Thibult N., Warnet J.M., Claude J.R., Rosselin G.E. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes results from the 11-year follow-up of the Paris Prospective Study . Diabetologia. 32:1989;300-304.
12. Manninen V., Tenkanen L., Koskinen P., Huttunen J.K., Manttari M., Heinonen O.P., Frick M.H. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study implications for treatment . Circulation. 85:1992;37-45.
13. Assmann G., Schulte H., von Eckardstein A. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol. 77:1996;1179-1184.
14. Stampfer M.J., Krauss R.M., Ma J., Blanche P.J., Holl L.G., Sacks F.M., Hennekens C.H. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 276:1996;882-888.
15. Rapp J.H., Lespine A., Hamilton R.L., Colyvas N., Chaumeton A.H., Tweedie-Hardman J., Kotite L., Kunitake S.T., Havel R.J., Kane J.P. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb. 14:1994;1767-1774.
16. Miller M., Seidler A., Moalemi A., Pearson T.A. Normal triglyceride levels and coronary artery disease events the Baltimore Coronary Observational Long-Term Study . J Am Coll Cardiol. 31:1998;1252-1257.
17. Havel R.J., Rapaport E. Management of primary hyperlipidemia. N Engl J Med. 332:1995;1491-1498.
18. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
19. Knopp R.H. Drug treatment of lipid disorders. N Engl J Med. 341:1999;498-511.
20. Austin M.A., Hokanson J.E., Edwards K.L. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol. 81:1998;7B-12B.
21. Reardon M.F., Nestel P.J., Craig I.H., Harper R.W. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation. 71:1985;881-888.
22. DeFronzo R.A., Ferrannini E. Insulin resistance. a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 14:1991;173-194.
23. Howard B.V. Lipoprotein metabolism in diabetes mellitus. J Lipid Res. 28:1987;613-628.
24. Nieves DJ, Cnop M, Retzlaff B, Walden CE, Brunzell JD, Knopp RH, Kahn SE. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes 2003;52:172-179.
25. Denke M.A., Sempos C.T., Grundy S.M. Excess body weight an underrecognized contributor to high blood cholesterol levels in white American men . Arch Intern Med. 153:1993;1093-1103.
26. Cnop M., Landchild M.J., Vidal J., Havel P.J., Knowles N.G., Carr D.R., Wang F., Hull R.L., Boyko E.J., Retzlaff B.M., et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations distinct metabolic effects of two fat compartments . Diabetes. 51:2002;1005-1015.
27. Walden C.E., Knopp R.H., Wahl P.W., Beach K.W., Strandness D.E. Jr. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N Engl J Med. 311:1984;953-959.
28. Siegel R.D., Cupples A., Schaefer E.J., Wilson P.W. Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham Offspring Study. Metabolism. 45:1996;1267-1272.
29. Knopp R.H., Broyles F.E., Bonet B., Walden C.E. Exaggerated lipoprotein abnormalities in diabetic women compared to diabetic men possible significance for arteriosclerosis . Wenger N.K., Speroff L., Packard B. Proceedings of a National Heart Lung and Blood Conference Cardiovascular Health and Disease in Women . 1993;131-138 LeJacq Communications, Greenwich, CT.
30. Kannel W.B., McGee D.L. Diabetes and cardiovascular risk factors the Framingham Study . Circulation. 59:1979;8-13.
31. Pietri A., Dunn F.L., Raskin P. The effect of improved diabetic control on plasma lipid and lipoprotein levels a comparison of conventional therapy and continuous subcutaneous insulin infusion . Diabetes. 29:1980;1001-1005.
32. Lopes-Virella M.F., Wohltmann H.J., Mayfield R.K., Loadholt C.B., Colwell J.A. Effect of metabolic control on lipid, lipoprotein, and apolipoprotein levels in 55 insulin-dependent diabetic patients a longitudinal study . Diabetes. 32:1983;20-25.